Mdm4 (MdmX) is a p53-binding protein that shares structural similarities with Mdm2 and has been proposed to be a negative regulator of p53 function. Like Mdm2, the absence of Mdm4 has recently been found to induce embryonic lethality in mice that is rescued by p53 deletion. Mdm4-null embryos are reduced in size and die at midgestation, and Mdm4-deficient embryos and embryonic fibroblasts displayed reduced rates of cell proliferation. The p53-induced, cyclin-dependent kinase inhibitor p21 is strongly upregulated in Mdm4-null embryos and cells. Here, we report that deletion of p21 delays the midgestation lethality observed in Mdm4-null mice, suggesting that Mdm4 downregulates p53-mediated suppression of cell growth. Surprisingly, the absence of p21 also uncovers an antiproliferative effect of Mdm4 on cell growth in vitro and in Mdm4-heterozygous mice. These results indicate that p21 is a downstream modifier of Mdm4, and provides genetic evidence that Mdm4 can function to regulate cell growth both positively and negatively.
Activity of the p53 tumor-suppressor protein is increased in cells exposed to DNA-damaging agents or certain forms of stress, leading to increased expression of regulatory proteins that inhibit cell growth or promote cell death (reviewed in Ryan et al., 2001 ). In addition, p53 has been found to induce the expression of the p53-binding protein Mdm2 (Barak et al., 1993; Wu et al., 1993) . We and others have previously demonstrated that Mdm2 is a critical negative regulator of p53 activity during development, as the absence of Mdm2 induces early embryonic lethality in mice that is completely rescued by deletion of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995) . Mdm2-null embryos have fewer cells, a disorganized architecture, and die around E5.5 of development. Although the early embryonic lethality of Mdm2-null mice makes it difficult to determine which p53 functions are being downregulated by Mdm2 during development, the absence of p21 does not rescue Mdm2-null mice, suggesting that Mdm2 may be specifically downregulating the apoptotic functions of p53 (Montes de Oca Luna et al., 1997) .
Mdm4 (MdmX) is a p53-binding protein with structural similarities to Mdm2, including an aminoterminal, p53-binding region and zinc RING finger domain (Shvarts et al., 1996) . Although both Mdm2 and Mdm4 can inhibit p53-mediated transactivation of heterologous gene expression, only Mdm2 appears to function as an E3 ligase to ubiquitinate and target p53 for proteosome degradation. However, the absence of Mdm4 also has been found to induce embryonic lethality in mice that is rescued by p53 deletion (Parant et al., 1997; Finch et al., 2002; Migliorini et al., 2002) . Mdm4-null embryos are reduced in size and die at midgestation (E7.5-E12), and Mdm4-null embryos and mouse embryonic fibroblasts (MEFs) display reduced rates of cell proliferation (Finch et al., 2002; Migliorini et al., 2002) . Interestingly, the expression of the cyclindependent kinase inhibitor p21, a p53-inducible gene, was strongly upregulated in both Mdm4-null embryos and MEFs (Parant et al., 2001; Migliorini et al., 2002) , suggesting that p21 may act as a downstream mediator of the effects of Mdm4 loss on cell growth and development.
In order to assess the functional significance of p21 upregulation in Mdm4-null mice, we crossed Mdm4-deficient mice (C57Bl/6 Â 129Sv background) with p21-null mice (C57Bl/6 background) (Deng et al., 1995; Finch et al., 2002) . Intercrossing of Mdm4-heterozygous mice did not result in recovery of viable Mdm4-null mice at E13.5 (data not shown), in keeping with the previously reported time of lethality (E7.5-E12) for Mdm4-null mice. Breeding of Mdm4-heterozygous mice with p21-null mice resulted in the generation of compound heterozygous mice that were then intercrossed to place the mutant Mdm4 allele onto a p21-null genetic background. Viable Mdm4-null mice were not recovered from intercrosses of Mdm4-heterozygous, p21-null mice (Table 1) . Thus, unlike p53 loss, deletion of p21 does not completely rescue Mdm4-null mice. However, Mdm4-null embryos were obtained after E8.5-E12 in development, indicating that the absence of p21 can induce a partial rescue of the mid-gestation lethality of Mdm4-null mice. Mdm4, p21-double-null mice were recovered as late as E15.5 of gestation, although the reduction in numbers of double-null mice present at day E14.5-E15.5 and the recovery of Mdm4, p21-double-null embryos that were much smaller than either Mdm4-heterozygous, p21-null littermates or p21-null littermates indicates that the absence of p21 only partially rescues Mdm4 deletion at this stage of development. No Mdm4, p21-double-null mice were recovered beyond day 15.5 from these crosses.
MEFs that are heterozygous for functional Mdm4 have been previously reported to proliferate more slowly than wild-type MEFs and, similar to Mdm4-null MEFs, display increased amounts of p21 (Migliorini et al., 2002) . In contrast, the proliferation rates of Mdm4/p53-double-null MEFs and p53-null MEFs are indistinguishable (Finch et al., 2002; Migliorini et al., 2002) . These findings suggest that the absence of Mdm4 leads to upregulation of p53, induction of p21, and subsequent inhibition of cell growth. In order to elucidate the role of p21 in the altered cell growth of Mdm4-deficient cells, we generated MEFs from E12.5 embryos harvested from Mdm4-heterozygous, p21-null mouse intercrosses and characterized their growth. Cells haploinsufficient for Mdm4 had fewer cells present in the S phase of the cell cycle and proliferated more slowly than wild-type MEFs, whereas p21-null MEFs displayed increased BrdU uptake and proliferated faster than either Mdm4-heterozygous or wild-type MEFs (Figure 1a ), in agreement with previous reports (Deng et al., 1995) . FACs analysis of p21-null and Mdm4-het.p21-null MEFs. Subconfluent cells were synchronized by growth in 0.1% serum for 4 days, released from serum, harvested at 0 or 18 h, and stained with propidium iodide. The percentages of cells in G1, S, G2, and 4G2 stages of the cell cycle are given in each plot. p21-null MEFs haploinsufficient for Mdm4 progress much more rapidly through the cell cycle than p21-null MEFs, displaying fewer cells in G1 and a larger 4G2 content. (c) Multiple dishes of duplicate lines of lowpassage (passage 2) MEFs for each genotype were plated at 2 Â 10 5 cells/60 mm dish and grown in DMEM with 10% FBS. Triplicate plates of each line of cells were harvested every 24 h and cell numbers were determined using a Beckman Coulture Counter. The mean cell count for the duplicate lines plus standard deviation is given. The doubling time was calculated for wild-type MEFs, p21-null MEFs, and Mdm4-het.p21-null MEFs in this experiment and is given below the proliferation curves Surprisingly, p21-null MEFs haploinsufficient for Mdm4 proliferated faster than p21-null MEFs. To analyse the cell cycling characteristics of these cells further, subconfluent p21-null MEFs and p21-null, Mdm4 þ /À MEFs were synchronized by serum deprivation (0.1% serum for 4 days). Mdm4 þ /À, p21-null MEFs progressed more rapidly through the cell cycle than p21-null MEFs, with fewer cells in G1 and more cells passing through the G2 phase at 18 h following release of cells from G1 arrest (Figure 1b) . To confirm that a reduction in Mdm4 gene dosage increased the growth of p21-null MEFs, we performed proliferation assays (Figure 1c) . The rate of cell growth of p21-null cells is significantly increased when one copy of the Mdm4 gene is inactivated. Thus deletion of p21 uncovers an antiproliferative effect of Mdm4 on cell growth.
Although mice deficient for p21 undergo normal development (Deng et al., 1995) , these mice develop spontaneous sarcomas and B-cell lymphomas at an average age of 16 months (Martin-Caballero et al., 2001 ). Since we were unable to recover viable Mdm4-p21-double-null mice from our crosses, we generated a cohort of Mdm4-heterozygous, p21-null mice for analysis. Interestingly, 19% (7/37) of Mdm4-heterozygous, p21-null mice spontaneously developed severe papillary epidermal hyperplasia on the snout by 12 weeks of age. Numerous mitotic events are observed in hematoxylin and eosin (H&E) staining of sections of the nasal epidermal layer (Figure 2a, c) , and increased cell proliferation was confirmed by immunohistochemistry using antibodies to Ki67 and proliferating cell nuclear antigen (PCNA), both markers of mitosis (Figure 2e, g ). Affected mice display increased epidermal thickening extending into the meatus of the nasal passages, leading to labored breathing and a gradual loss of body weight likely due to reduced food intake. We have not observed this phenotype in p21-null mice wild type for Mdm4 (n ¼ 20), nor have we seen this hyperplasia in Mdm4-heterozygous mice (n ¼ 28), p53-heterozygous or p53-null mice (n4200) (Donehower et al., 1992) , or in p53-null mice that are Mdm2-heterozygous (n450) or Mdm2-null (n4100) (Jones et al., 1996) . These data provide in vivo support for a role for Mdm4 in negatively regulating cell growth in the absence of p21.
It is unclear at present why haploinsufficiency of Mdm4 results in increased cell growth in p21-null cells and mice. Recently, Mdm4 has been reported to associate with E2F1 and to down regulate the ability of E2F1 to bind to E2F1 consensus DNA sequences (Strachan et al., 2003) . E2F1 is a member of the E2F family of proteins that regulate the transcription of genes necessary for progression of cells into the S phase. The p21 protein is a negative regulator of E2F1 activity, and we have observed that cells lacking p21 display excess levels of E2F1 protein. Therefore, it is possible that Mdm4 serves to down regulate excess E2F1 in p21-null mice and cells. Interestingly, although Ki67 staining and PCNA staining were observed in the nasal epithelium of Mdm4-het, p21-null mice indicating excess cell proliferation, there were many more cells staining strongly positive for PCNA, which is encoded by an E2F1-responsive gene (DeGregori et al., 1995) .
The inability of one Mdm2 family member to compensate for loss of the other in gene targeting experiments in mice has led to the proposal that Mdm4 and Mdm2 play nonoverlapping roles in regulating p53 activity, with Mdm4 downregulating p53-mediated suppression of cell growth and Mdm2 negatively regulating p53-mediated apoptosis (Parant et al., 2001) . However, it is unlikely that regulation of different p53 functions by Mdm2 and Mdm4 is completely distinct, as p53-induced apoptosis was detected in the developing central nervous system of Mdm4-null mice (Migliorini et al., 2002) . Recent biochemical evidence indicates that Mdm4 functions to assist Mdm2 in Immunohistochemistry performed on sections of paraffin-embedded, nasal papillary epithelial mass harvested from Mdm4-heterozygous, p21-null mouse using primary antibodies against either (e) the nuclear, cell proliferation-associated antigen Ki67 or (g) PCNA. Staining of sections from p21-null mouse nose are shown in (f) (Ki67) and (h) (PCNA) as controls regulating p53 activity by complexing with Mdm2 and stabilizing the levels of Mdm2 in the cell (Gu et al., 2002) . This model suggest that Mdm2 and Mdm4 would similarly regulate p53 functions. Although confirmation of this overlap model awaits the identification of the precise p53 functions regulated by Mdm2 and Mdm4, our data are consistent with this proposed model in that the absence of p21 fully rescues neither Mdm2-null mice nor Mdm4-null mice. However, the differences in the timing of embryonic demise in Mdm2-null mice and Mdm4-null mice, as well as the ability of p21 deletion to delay the embryonic lethality of Mdm4-null mice but not Mdm2-null mice, suggests that Mdm2 and Mdm4 do differentially regulate some aspects of p53 function. Furthermore, our data uncover an antiproliferative role for Mdm4 in cell growth that is distinct from Mdm2-mediated regulation of p53. It remains to be seen if haploinsufficiency of Mdm4 increases the onset of tumorigenesis in p21-wild-type or p21-null mice. A more detailed analysis of the role of Mdm4 in tumorigenesis is presently ongoing.
